UBS Group’s Syra Health Corp. Class A Common Stock SYRA Stock Holding History

UBS Group’s Portfolio SYRA Stock Details SYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-19,440	Closed	-$5.05K	–	11173
2025 Q1	$5.05K	Buy	19,440 +17,949	+1,204%	+$7.53K	﹤0.01%	9035
2024 Q4	$614	Buy	+1,491	New	+$600	﹤0.01%	9407
2024 Q3	–	Sell	-1,665	Closed	-$2.28K	–	10243
2024 Q2	$2.28K	Sell	1,665 -1,791	-52%	-$2.45K	﹤0.01%	8389
2024 Q1	$4.77K	Buy	+3,456	New	+$5.58K	﹤0.01%	7593
2023 Q4	–	Sell	-396	Closed	-$1.19K	–	10040
2023 Q3	$1.19K	Buy	+396	New	+$1.19K	﹤0.01%	8056

Other funds holding SYRA

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

UBS Group's SYRA Position: Q2 2025 in Review

UBS Group sold out of Syra Health Corp. Class A Common Stock (SYRA) in Q2 2025, closing a stake of 19,440 shares — an estimated $5.05K sold.

UBS Group first reported a position in SYRA in Q3 2023 and held it in 5 quarters. The position peaked at $5.05K in Q1 2025. 2 funds tracked by Wall St. Rank hold SYRA as of Q2 2025.

UBS Group reported no remaining Syra Health Corp. Class A Common Stock position as of Q2 2025 after selling out during the quarter.
UBS Group sold 19,440 Syra Health Corp. Class A Common Stock shares in Q2 2025, an estimated $5.05K.
UBS Group first reported a position in Syra Health Corp. Class A Common Stock in Q3 2023 and held it in 5 quarters.
UBS Group's Syra Health Corp. Class A Common Stock position peaked at $5.05K in Q1 2025.
2 funds tracked by Wall St. Rank held Syra Health Corp. Class A Common Stock as of Q2 2025.

Based on UBS Group's 13F filing for Q2 2025, filed 14 Aug 2025.